Ventyx Biosciences
VTYX
VTYX was delisted on the 3rd of March, 2026.
118 hedge funds and large institutions have $114M invested in Ventyx Biosciences in 2024 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 44 increasing their positions, 30 reducing their positions, and 18 closing their positions.
47% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 30
9% more call options, than puts
Call options by funds: $314K | Put options by funds: $288K
6% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 18
1% more funds holding
Funds holding: 117 → 118 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6.95% less ownership
Funds ownership: 81.21% → 74.26% (-6.9%)
13% less capital invested
Capital invested by funds: $132M → $114M (-$17.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$2.74M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.7M |
| 3 |
DM
Deerfield Management
New York
|
+$2.04M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.11M |
| 5 |
Goldman Sachs
New York
|
+$1.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$12.1M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$3M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.75M |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$2.68M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.66M |
VTYX Hedge Fund Activity: Q3 2024 in Review
118 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q3 2024, worth a combined $114M — down 13% from $132M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new VTYX positions and 18 closed out — a net gain of 1 holder — while 44 added to existing stakes and 30 trimmed.
The largest buyer was Sio Capital Management, adding an estimated $2.74M. The largest seller was Capital International Investors, exiting entirely with an estimated $12.1M sold.
- 118 institutional investors held Ventyx Biosciences (VTYX) as of Q3 2024, up from 117 in Q2 2024.
- Funds reported $114M of Ventyx Biosciences stock for Q3 2024, down 13% quarter-over-quarter.
- 19 funds opened new Ventyx Biosciences positions in Q3 2024 and 18 closed out, a net change of +1 holder.
- The largest Ventyx Biosciences buyer in Q3 2024 was Sio Capital Management, an estimated $2.74M added.
- The largest Ventyx Biosciences seller in Q3 2024 was Capital International Investors, an estimated $12.1M sold.
Based on aggregated 13F filings for Q3 2024.